우리나라 소아 Helicobacter pylori 감염 제균치료 경험 - 파일럿 조사연구

우리나라 소아 Helicobacter pylori 감염 제균치료 경험 - 파일럿 조사연구

National survey of Helicobacter pylori treatment for children in Korea: Pilot study

(포스터):
Release Date : 2017. 10. 26(목)
Jong-Hyuck Youn1,1,1, Ji-Hyun Seo1,1,1, Jae-Young Kim1,1,1, Hee-Shang Youn1,1,1, Jae Sung Ko2,2,2, Kyung Mo Kim3,3,3 , Ju-Young Chung4,4,4
Gyeongsang National University Hospital Department of Pediatrics1
Seoul National Univesity Children's Hospital Department of Pediatrics2
Ulsan University Asan Medical Center Department of Pediatrics3
Inje University Sanggye Paik Hospital Department of Pediatrics4
윤종혁1,1,1, 서지현1,1,1, 김재영1,1,1, 윤희상1,1,1, 고재성2,2,2, 김경모3,3,3 , 정주영4,4,4
경상대학교병원 소아청소년과학교실1
서울대학교 어린이병원 소아청소년과학교실2
울산의대 서울아산 어린이병원 소아청소년과학교실3
인제대학교 상계백병원 소아청소년과학교실4

Abstract

The standard guideline for the management Helicobacter pylori infection in Korean children is not present until now. In present study, we conducted the questionnaire survey to investigate the real situation of H. pylori eradication in children. Questionnaire concerning the indications of H. pylori eradication, the first choice of treatment modality, the decision method of eradication result, experience of eradication failure, the second choice of treatment modality was sent to doctors who are members of the Korean Society for Pediatric Gastorenterology, Hepatology, and Nutrition. A total of 28 doctors (90.3%) answered the questionnaires among 31 doctors. The most common indication for eradication of H. pylori was peptic ulcer (n=24) followed by chronic abdominal pain (n=17) and positive family history of gastric cancer (n=12). The most common choice of first-line eradication therapy was omeprazole, amoxicillin, clarithromycin triple therapy (n=21) and followed by bismuth subsalicylate, amoxicillin, metronidazole, clarithromycin quadruple therapy (n=7). The results of treatment were judged by C13-urea breath test after 2 months later in 21 doctors (75.0%). Twenty four (85.7%) out of 28 doctors had experienced treatment failure. The most common second-line therapy was the sequential therapy (58.3%, 14 doctors among 24). This was the first study for the survey of the treatment of H. pylori infection to Korean pediatricians. The results of this study showed that most pediatric gastroenterologists used to treat H. pylori infection according to the textbook and the common use of bismuth-based quadruple therapy for the first-line treatment was notable.

Keywords: Helicobacter pylori infection, treatment, children